期刊文献+

3D-QSAR and action mechanism of potential dual inhibitors towards AP-1 and NF-κB

3D-QSAR and action mechanism of potential dual inhibitors towards AP-1 and NF-κB
在线阅读 下载PDF
导出
摘要 Three-dimensional quantitative structure-activity relationship(3D-QSAR)and docking studies of a series of novel dioxopyrrolinyl-amino-pyrimidine derivatives,which are potential dual inhibitors mediating a transcriptional activation towards protein-1(AP-1)and nuclear factor kappa B(NF-κB),have been carried out.The QS,AR models established by comparative molecular field analysis(CoMFA)and comparative molecular similarity index analysis(CoMSIA)show a good predictive ability with cross-validated coefficients q2 of 0.644 and 0.636,respectively.The docking result shows that there are quite lower average values of the flexible and rigid energy scores on the selected binding sites,meanwhile,it further shows that the binding sites just fall on the joint regions between AP-1(and NF-κB)and DNA.The reason that these analogues have inhibition function towards AP-I and NF-κB is that their existence on these joint regions can effectively prevent free AP-I and NF-κB from binding to DNA.These results can offer a valuable theoretical reference to the pharmaceutical molecular design as well as the action mechanism analysis.
出处 《Journal of Chemistry and Chemical Engineering》 2009年第1期1-12,共12页 化学与化工(英文版)
基金 the financial supports of the National Natural Science Foundation of China(Nos.:20673148 and 90608012)
关键词 pyrimidine derivative 3D-QSAR docking analysis activator protein-1 nuclear factor kappa B QSAR 机制分析 抑制剂 AP 比较分子相似性指数分析 3D 三维定量构效关系 比较分子力场分析
  • 相关文献

参考文献27

  • 1Palanki, M. S. S. and Manning, A. M.. lnterleukin-2 inhibitors in autoimmune disease. Exp. Opin. Ther. Patents., 1999, 9: 27-39.
  • 2Palanki, M. S. S., Erdman, P. E., Manning, A., et al. Novel inhibitors of AP-I and NF-kappa B mediated gene expression: Structure-activity relationship studies of ethyl -4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoro methyl)pyrimidine-5-carboxylate. Bioorg. Med Chem. Lett., 2000, 10: 1645-1648.
  • 3Manning, A. M. and Lewis, A. J.. New targets for anti-inflammatory drugs. Curr. Opin. Chem. Biol., 1999, 3: 489-494.
  • 4Palanki, M. S. S.. Inhibitors of AP-I and NF-kappa B mediated transcriptional activation: Therapeutic potential in autoimmune diseases and structural diversity. Curr. Med. Chem., 2002, 9: 219-227.
  • 5Isayev, O., Rasulev, B., Gorb, L., et al. Structure-toxicity relationships of nitroaromatic compounds. Mol. Divers., 2006, 10: 233-245.
  • 6LI R. L.. Drug Structure-Activity Relationship(lst ed.). Beijing: Chinese Medicine Science and Technology Press, 2004: 477.
  • 7LIAO S. Y,, QIAN L., CHEN J. C., ~t al. 2D and 3D-QSAR studies on antiproliferative thiazolidine analogs. Int. J. Quantum. Chem., 2008, 108: 1380-1390.
  • 8LIAO S. Y., CHEN J. C., QIAN L.,et al. QSAR studies and molecular design of phenanthrene-based tylophorine derivatives with anticancer activity. QSAR. Comb. Sci., 2008, 27: 280-288.
  • 9Basak, S. C., Mills, D. and Hawkins, D. M.. Predicting allergic contact dermatitis: a hierarchical structure-activity relationship (SAR) approach to chemical classification using topological and quantum chemical descriptors. J. Comput. Aided Mol. Des., 2008, 22: 339-343.
  • 10Cramer, R. D., Patterson, D. E. and Bunce, J. D.. Comparative molecular field analysis (CoMFA). 1. effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc., 1998, 110: 5959-5967.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部